no Mr47 it raises the same residual royalty/milestone payments issue that AVX has with Shire...a significant reason IMO hindering a viable partnering deal...even when armed with statistically significant clinical data.
Your reply clearly displays that you a rank amateur in this sector and will clutch at any spin possible to keep the dream alive.
The emperor is wearing no clothes!
martin rogers says cvac rights 100% prr, page-22
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.025(7.81%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $1.891M | 6.244M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 544309 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 69039 | 10 |
View Market Depth
| Last trade - 14.28pm 16/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |